A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)
Fondazione Italiana Linfomi - ETS
Fondazione Italiana Linfomi - ETS
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
St. Joseph's Hospital and Medical Center, Phoenix
The First Affiliated Hospital of Soochow University
Gilead Sciences
Ludwig-Maximilians - University of Munich
Mundipharma (China) Pharmaceutical Co. Ltd
Henan University of Traditional Chinese Medicine
The University of Hong Kong
Assistance Publique - Hôpitaux de Paris
Wuhan University
Wuhan University
National Research Center for Hematology, Russia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fondazione Italiana Linfomi - ETS
Ativus Farmaceutica Ltda
National Cancer Institute (NCI)
Azienda Ospedaliera San Giovanni Battista
Makerere University